Clinical trials regulatory approval timeliness rate
Share of clinical trial applications receiving regulatory approval decisions within standard timeframes.
Unit Percent Industry Pharmaceuticals
The chart
The figure
One published observation so far. A chart follows as soon as a second period is published.
Clinical trials regulatory approval timeliness rate
United Kingdom, as of 8 Sep 2026
Every record
All records
1 record · 1 region · 2026
| Period | Value | Source | Type |
|---|---|---|---|
| United Kingdom 1 record | |||
| as of 8 Sep 2026 | 98% | ABPI · 8 Sep 2026 | actual |
Primary documents
Sources
1 document. Each links to the publisher's own copy.
| Document | Publisher | Published | Data points |
|---|---|---|---|
| Green shoots for UK pharma investment, but delivery will decide whether they take root | ABPI | — | 1 |
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.
StatOrigin. (2026). Clinical trials regulatory approval timeliness rate. Retrieved from https://statorigin.org/indicators/clinical-trials-regulatory-approval-timeliness-rate